MLH - Main Line Health Inc (via Public) / Back in life s flow: Trials provide increased options to treat heart valve disease publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
Bicuspid Aortic TAVR May Create Huge Market For Transcatheter Valves
February 4, 2021 Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the patients with bicuspid valve valves, but recent studies may soon open the door to wider use of TAVR in this population.
“Physicians have previously been cautious about using TAVR in patients with bicuspid valve stenosis due to a number of factors, explained Ashley Young, senior medical devices analyst at GlobalData healthcare market research. Perhaps most importantly, the long-term durability of TAVR valves has yet to be thoroughly proven in a robust clinical trial setting. This is of utmost importance to patients with bicuspid aortic valve anatomy, who typically present with stenosis at a younger age and depend on long-term durability of replacement valves.”